International Journal of Tuberculosis and Lung Disease

Article	Citations
TB infection in adults with diabetes mellitus in Uganda	147
Clinical profile and outcomes of paediatric central nervous system tuberculomas	109
TB-related deaths among adults in Guinea-Bissau	82
Launch of a second wave of IJTLD Clinical Standards for Lung Health	54
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	47
Dr Christopher Zishiri	43
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	43
Screening of refugees from Ukraine for TB: a TBnet survey	42
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	32
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	30
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	30
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	27
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	26
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	24
Latent TB and depressive symptoms in household contacts of persons with active TB	22
Yield of community outreach events for TB screening	21
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments	19
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	18
WHO target product profiles for TB preventive treatment	18
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	17
TB in ageing populations: lessons from Japan and Korea	17
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	17
The impact of sputum quality on Xpert positivity in active case-finding for TB	16
The COVID-19 pandemic does not bode well for TB control	15
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	15

Are schools prepared to manage students with an asthma attack?	15
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	14
Standards for clinical trials for treating TB	14
Literature Highlights	14
Assessment of TB patient cost – what about the mitigation strategy?	14
Accessibility and TB patient satisfaction in Nigeria	13
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	13
Performance of spirometry assessment at TB diagnosis	13
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	13
Occupational transmission of TB infection during autopsy	13
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	13
TB disease yield from household contact screening of TB index patients in Pakistan	12
A cohort study exploring variables associated with mortality in critically ill TB patients	12
Perceived stigma among people with TB and household contacts	12
TB testing in HIV-positive patients prior to antiretroviral treatment	12
Prevalence of chronic airflow obstruction in sub-Saharan Africa	12
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	11
Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children	11
Patterns of TB transmission in the United States, 2011–2017	11
Post-TB lung disease: keep going beyond TB!	11
A novel method for contact tracing for TB at household and community level	10
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	10
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	10
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	10
Facilitators and barriers to adolescent participation in a TB clinical trial	10
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services	10
Paediatric TB care in the United Kingdom	10
Updated guidelines for child and adolescent TB	10
Population attributable fraction for smoking and diabetes in TB	10
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	9
Risk factors for severe COPD exacerbation in Chinese adults	9
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	9
Health status of Italian children living close to cultivations sprayed with pesticides	9
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	9
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	9
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	9
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	9
Evaluation of QFT-Plus performance using blood samples stored at room temperature	8
Protecting healthcare workers from TB	8
Cascade of care for people with TB and diabetes in India	8
Medical management of large and multiple pulmonary echinococcal cysts	8
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	8
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	8
Perceived stigma related to TB preventive therapy	7
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	7
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	7
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	7
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	7
Financial impact of COVID-19 on TB patients in India	7

Community-based intervention and health education to scale up TB preventive treatment for children	7
Use of computed tomography for the diagnosis of TB during a paediatric outbreak	7
The effect of systematic screening of the general population on TB case notification rates	7
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	7
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	7
Contribution of Xpert® MTB/RIF to pediatric TB diagnosis in Mozambique	7
Characteristics, risk factors and outcomes of critically ill patients with active TB	7
Meeting of two pandemics in prison: a challenging event in a challenging environment	7
TB notifications among citizens and non-citizens in Taiwan	7
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	7
Cost of TB prevention and treatment in the Philippines in 2017	7
If you want to go far, go together: standardisation and data sharing in TB drug development	7
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB	7
Extemporaneously compounded liquid formulations of clofazimine	6
TB mortality in low-incidence countries: can we reduce it further?	6
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	6
TB and COVID-19 co-infection in a pulmonology hospital	6
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	6
TB and chronic pulmonary aspergillosis: a few relevant points	6
The high costs facing TB-affected households in Mali	6
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	6
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	6
Predictors of TB disease in HIV-exposed children from Southern Africa	6
Impact of COVID-19 on hospitalisations for asthma	6
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	6
Diabetes characteristics and long-term management needs in diabetic TB patients	6
Estimating TB survival ‐ mind the immortal-time gap	6
Time to integrate epidemiological and economic models for TB	6
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	6
A new understanding of clinical patterns in post-TB lung disease	6
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	6
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	6
Urine LAM diagnostics can close the deadly testing gap for TB	6
Mycobacterium tuberculosis genotypes isolated from clinical specimens of extrapulmonary TB	6
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	6
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	6
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	6
Bronchiectasis exacerbations: certainties and future challenges	6
Clinical experience of TB in patients treated with anti-TNF-α	6
Rifampicin-resistant TB: discordance between Xpert® MTB/RIF and MTBDRplus results	6
Effect of biological therapies on TB treatment outcomes	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
Glutathione and N-acetylcysteine in TB management	5
Implementation of modified, all-oral shorter TB regimens in Armenia	5
TB screening, prevention and treatment cascade in a Malawi prison	5
TB screening of children from Ukraine in Germany	5
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	5
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	5
Early line-probe assay using DNA specimens in patients with pulmonary TB	5
TB screening of Ukrainian refugees in Germany	5
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	5
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	5
WHO drug-resistant TB guidelines 2022: what is new?	5
Family directly observed therapy for children with drug-resistant TB	5
Early mortality during rifampicin-resistant TB treatment	5
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	5
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	5
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	5
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	5
Literature Highlights	5
National approaches to TB care in adolescents	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	5
Factors associated with presenting to private sector care providers at the onset of TB symptoms	5
Potential use of nasopharyngeal aspirate for pediatric TB diagnosis	5
Impact of the COVID-19 pandemic on TB infection testing	5
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	5
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	5
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	5
A bold new future for the IJTLD	5
After DOT, the brave new world?	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	5
Interventions to enhance treatment adherence and retention in care for HIV-TB	4
Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	4
Programmatic implications of a sub-national TB prevalence survey in India	4
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	4
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	4
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	4
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	4

Clinical outcomes in comorbid COVID-19 and TB cases	4
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	4
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	4
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing	4
A comprehensive person-centred TB care model, from malnutrition to mental health	4
Eosinophils in bronchiectasis: searching for a new endotype	4
Concomitant pulmonary disease is common among patients with extrapulmonary TB	4
Bridging the gap: key evidence needed to strengthen global policies to end TB	4
Factors associated with referrals for directly observed treatment and unsuccessful treatment	4
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	4
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	4
Launch of the IJTLD Clinical Standards for Lung Health	4
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	4
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
Post-TB bronchiectasis: clinical characteristics and microbiology	4
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	4
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	4
Borderline T-SPOT.TB results: test reliability, patient characteristics, and TB progression	4
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Preventive treatment for MDR-TB exposure in households	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
A comparison of bronchoalveolar lavage and gastric aspirate for diagnosis of paediatric TB	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Artificial intelligence for TB education and counselling: a modified Delphi consensus	3
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
An adapted scale to measure perceived TB and HIV stigma during household contact investigation	3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	3
Prevalence, temporal trends and risk factors of drug-resistant TB in Zibo, China, 2018–2021	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Adverse events among persons with TB using in-person vs. electronic directly observed therapy	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Electronic nicotine delivery system use among current smokers in India	3
TB in the elderly: clinical features and outcomes	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Outcomes for people with TB by disease severity at presentation	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
Therapeutic drug monitoring for isoniazid and rifampicin exposure	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
Introduction of new drugs for drug-resistant TB in Iraq	3
Ocular TB in Western Australia	3
Reply to: “TB and chronic pulmonary aspergillosis: a few relevant points”	3
Work-related interstitial lung diseases: reassessing the burden	3
Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda	3
Time to care-seeking for TB symptoms	3
A structured 2-week follow-up visit in the cascade of care for TB increases case detection	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
The interplay between TB and lung cancer: risk, prognosis and treatment dynamics	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
The scientific response to TB – the other deadly global health emergency	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
Highlighting the characteristics of TB disease in older people	3
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	3
The economic burden of TB-affected households in DR Congo	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Male reproductive hormones in patients treated with pretomanid	3
Towards meaningful inclusion of people affected by TB: lessons from the COVID-19 response	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
Ukraine embraces innovation in its fight against another deadly foe: TB	3
The effect of TB patient delay on loss to follow-up in Portugal	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
Co-administration of treatment for drug-resistant TB and hepatitis C	2
Omadacycline enhances the in vitro activity of clofazimine against Mycobacterium abscessus	2
Implementing TB preventive therapy: lessons from a large-scale initiative in India	2
Ultrasound-guided lymph node biopsy in smear-negative children and adolescents with suspected TB	2
Response to: The pressing need for standardised diagnostic criteria for obstructive ventilatory impairment in adults and children	2
Improving enrolment for TB preventive treatment	2
Clinical and imaging characteristics associated with hospitalisation for post-TB lung disease	2
Incidence of tuberculous infection in a TB-endemic city	2
Screening for active and latent TB among migrants in France	2
Successes and challenges of latent TB screening and treatment in a high-prevalence US region	2
Does childhood TB or pneumonia impact COPD or asthma in adulthood?	2
Evaluating the impact of COVID-19 or SARS-CoV-2 vaccination on TB infection testing in the context of TB elimination	2
Scaling up shorter TB preventive treatment is long overdue	2
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	2
The cascade of care for household contacts of people with drug-resistant TB	2
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?	2
Limitations of using tuberculin skin test to screen for TB in patients with psoriasis	2
Did public-private partnerships reduce TB incidence in Korea?	2
Association of physical inactivity and handgrip strength with non-tuberculous mycobacterial pulmonary disease	2
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB	2
Comparison of pharmacokinetics and bioavailability of bedaquiline fumarate, benzoate and maleate in dogs	2
Tobacco cessation services in the Indian state of Uttarakhand	2
Low serum levels of anti-TB drugs in a high TB setting	2
Referral of presumptive TB among operators of community medicine outlets	2
Use of local data to evaluate TB contact investigation in Malawi	2
Does BCG vaccination protect against infection with M. tuberculosis?	2
Potential future impact of dupilumab on COPD	2
A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays	2